Research & Development: Page 57
-
SHOWCASE FEATURE: e-Solutions: The E-Arena
The E-Arena From the clinic to the medicine cabinet, e-solutions are transforming the way in which medicines are developed, monitored, and taken. Soaring healthcare costs across the globe, accompanied by growing demands from aging populations and emerging economies, are fueling technological and ...
By Taren Grom • Nov. 13, 2013 -
Commercialization Payers: The Power of Payer Partnerships Lies in Data Sharing
Year in Preview: Commercialization — Payers The Power of Payer Partnerships Lies in Data Sharing As payers grow more influential in treatment decision making, sharing outcomes data becomes key for pharma. Shared use of data between payers and pharma has been occurring for some time, but today — a...
By Taren Grom • Nov. 13, 2013 -
Explore the Trendline➔
Getty ImagesTrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
Commercialization Physicians: Improving Access to Physicians in 2014
Year in Preview: Commercialization Physicians Improving Access to Physicians in 2014 It will take more than technology to create successful relationships with physicians. The role of today’s pharmaceutical salesforce is in constant evolution, as is the environment in which it functions. As leaner...
By Taren Grom • Nov. 13, 2013 -
R&D Outsourcing: Outsourcing Relationships Mature
Year in Preview: R&d Outsourcing Outsourcing Relationships Mature The sponsor-CRO partnership continues to evolve toward an integrated ???? approach to clinical development that decreases fixed costs and provides sponsors with access to capabilities not found internally. R&D outsourcing w...
By Denise Myshko • Nov. 13, 2013 -
R&D Big Data: Big Data to Transform R&D
Big Data Transform R&D The use of big data is expected to be a disruptive innovation for research and development. The use of big data is expected to transform healthcare in general and the pharmaceutical in particular. The McKinsey Global Institute estimates that applying big-data strategies...
By Taren Grom • Nov. 13, 2013 -
R&D Collaboration: Thriving in an Era of R&D Collaboration
Thriving in a Era of R&D Collaboration Year in Preview: R&D collaboration Greater cooperation with academic and government researchers, as well as with other companies, is needed to create collaborations that push innovation forward. There is a growing consensus that the industry must tea...
By PharmaVoice Team • Nov. 13, 2013 -
R&D Trends: The Innovation Challenge
The Innovation Challenge Innovation continues to be a hot topic in pharma R&D. But developing truly innovative medicines will require companies to embrace nontraditional partnerships, have a focus on genomics to get a better understanding of disease, and adopt systems biology and big data app...
By Taren Grom • Nov. 12, 2013 -
Corporate Crystal Ball: Trends From the Top
Trends From the Top From the ACA to a value-based system, executives representing all aspects of the life-sciences industry name the top trends they believe will impact near- and long-term success. Phil Birch Senior VP, Global Strategic Marketing Aptiv Solutions 1. Value-Based System. The evolvin...
By Taren Grom • Nov. 12, 2013 -
Talent Pool
Pharma Pool Jesper Høiland Novo Nordisk Appoints New Leader of North American Affiliate Jesper Høiland has been named as president of Novo Nordisk Inc., the company’s North American affiliate. Mr. Høiland was previously Novo Nordisk’s head of International Operations where he oversaw all of the c...
By Ann Grey • Nov. 12, 2013 -
On the Calendar
The Calendar MHealthSummit — where technology, business, research, and policy connect. The largest event of its kind, the fifth annual mHealth Summit, December 8-11, 2013, Gaylord National Resort and Convention Center, Washington, D.C., brings together leaders in government, the private sector, i...
By Heather Hummel • Nov. 12, 2013 -
PharmaTrax
Trending Now: Shortcomings in e-prescribing systems hinder brand prescribing, challenging pharma to help improve systems. Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Physicians Find Obstacles for E-prescribing Study Addresses Launch and Pre-launch Budgets Mobile A...
By Denise Myshko • Nov. 12, 2013 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Almac Tool Streamlines Trial Supply Administration Accelrys Offers Integrated Predictive Sciences Solutions Intouch Enables Communications with Providers Updates Tools of the Trade Trending Now: Online tool provid...
By Denise Myshko • Nov. 12, 2013 -
What's New
TrendIng Now: Strategic initiative helps clients with changes to U.S. healthcare policy. New Healthcare-related Products, Services, and Companies Featured Briefs: inVentiv Health and Mehlman Vogel Castagnetti Launch Breakaway Policy Strategies FDA Forms Program Alignment Group INC Research Offers...
By Ann Grey • Nov. 12, 2013 -
UpFront
INDUSTRY at Large Lilly’s Global Day of Service Supports Indy DO Day Initiative Counterfeit Medicines: The New Face of Organized Crime Veeva Goes IPO In Memoriam Kathleen Drennan Awards… Genentech Researcher Receives Albert Lasker Award PhRMA Honors Vaccines Pioneers Wolters Kluwer wins Awards Po...
By Denise Myshko • Nov. 12, 2013 -
Letter from the Editor
2014 — Year in Preview From the ACA to social media, industry executives are providing their predictions on what’s hot for 2014. For this special annual issue of PharmaVOICE, we invited dozens of industry experts to provide their predictions on the emerging and current trends they expect to impac...
By Taren Grom • Nov. 12, 2013 -
Postmarket Surveillance Comes to the Device Industry
Postmarket Surveillance Comes to the Device Industry Device manufacturers have to meet new regulations that require them to have a more integrated postmarketing process for their products. The global medical device market was valued at $331 billion in 2012, 3% higher than 2011. Source: Kalorama I...
By Denise Myshko • Sept. 27, 2013 -
HIV Prevention Makes Strides
HIV Prevention Makes Strides New research is leading to vaccines and other pre-exposure prophylaxis therapies against HIV/AIDS. A modern day plague unchecked. That’s how the Centers for Disease Control describes HIV/AIDS. HIV, along with malaria and tuberculosis, represents a huge area of unmet n...
By Denise Myshko • Sept. 27, 2013 -
Talent Pool
BIOTECH POOL Kelly BLACKBURN aTyr Pharma Expands Leadership Team aTyr Pharma has expanded its executive leadership team. Kelly Blackburn joins aTyr as VP, clinical affairs. Ms. Blackburn was formerly VP, clinical development operations, at Vertex Pharmaceuticals, where she was responsible for the...
By Ann Grey • Sept. 27, 2013 -
PharmaTrax
Trending Now: The U.S. healthcare system could avoid hundreds of millions of dollars in medical costs if medication adherence rates improved. Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Adherence Can Lead to Healthcare Savings Sidebars: Adherence Trends Therapeuti...
By Denise Myshko • Sept. 27, 2013 -
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: CenterWatch and Study Scavenger Partner for Mobile Trials Solution RxVantage Unveils Free iPhone App for Pharma Reps Updates Communication Expert Launches New App Library Trending Now: The companies are partnering...
By Denise Myshko • Sept. 27, 2013 -
The Changing Face of South Korean Pharma
The Changing Face of South Korean PHARMA A growing market, regulatory changes, and a new global competitive environment are changing the face of the Korean pharma industry. With a population of close to 50 million people and an established economy, the Republic of Korea is now recognized as a dev...
By Kim Ribbink • Aug. 23, 2013 -
Where Have All The Investigators Gone?
The investigative site landscape has become highly fragmented and unstable with high turnover rates, declining numbers of experienced professionals, and limited infrastructure. More than half of all clinical trials worldwide that are regulated by the FDA were conducted by independent, community-b...
By Denise Myshko • Aug. 23, 2013 -
Patient Recruitment in the Online Era
Patient Recruitment in the Online Era Recruiting patients for clinical trials continues to be challenging. Social media may just be the answer. Despite the time, effort, and money spent on improving patient recruitment and retention, these two areas of clinical development remain among the bigges...
By Denise Myshko • Aug. 23, 2013 -
Last Word
Bridging Science and Patients Dr. Victoria Richon, VP of discovery and preclinical research oncology at Sanofi Oncology, discusses how translational medicine efforts are moving the company forward. Sidebar: Sanofi’s Commitment to Translational Medicine The Last Word PV: How do you define translat...
By PharmaVoice Team • Aug. 23, 2013 -
Talent Pool
Emerging POOL Dr. Deborah DUNSIRE EnVivo Pharmaceuticals Appoints President and CEO EnVivo Pharmaceuticals, a privately held company working to convert its broad pipeline into a range of CNS therapies that leverage novel mechanisms of action by altering the progression of disease and providing im...
By Ann Grey • Aug. 23, 2013